LISTED digital health company Medibio Limited has appointed Adam Darkins as deputy chairman of its board of directors.
Darkins, who has been based in the USA since 1997, joins Medibio from Medtronic PLC where he worked on new payment models to transform health care.
Medibio has developed an "objective test to assist with the diagnosis of depression, chronic stress and other mental health disorders," based on research conducted at the University of WA.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 17
